GH Research Plc (GHRS)
28.24
+0.32
(+1.13%)
USD |
NASDAQ |
Sep 04, 16:00
28.24
0.00 (0.00%)
After-Hours: 16:21
GH Research Cash from Investing (Quarterly) : 6.295M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.295M |
| March 31, 2026 | 8.637M |
| December 31, 2025 | 8.566M |
| September 30, 2025 | 10.46M |
| June 30, 2025 | 16.75M |
| March 31, 2025 | 11.84M |
| December 31, 2024 | 19.95M |
| September 30, 2024 | 15.86M |
| June 30, 2024 | 19.62M |
| March 31, 2024 | 8.788M |
| December 31, 2023 | 0.6247M |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0163M |
| June 30, 2023 | -0.434M |
| March 31, 2023 | -54.02M |
| December 31, 2022 | -82.15M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -0.01M |
| December 31, 2021 | -0.0169M |
| September 30, 2021 | -0.0486M |
| June 30, 2021 | -0.014M |
| March 31, 2021 | -0.021M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Atai Beckley, Inc. | 158.15M |
| Avadel Pharmaceuticals Plc | -8.788M |
| Jazz Pharmaceuticals Plc | 354.90M |
| Eli Lilly & Co. | -15.40B |
| Perrigo Co. Plc | 349.40M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.94M |
| Cash from Financing (Quarterly) | 111.51M |
| Free Cash Flow | -52.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2248 |
| Free Cash Flow to Equity (Quarterly) | -14.88M |
| Free Cash Flow to Firm (Quarterly) | -14.87M |
| Free Cash Flow Yield | -2.94% |